Cargando…

Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma

Diffuse midline gliomas (including diffuse intrinsic pontine glioma, DIPG) are highly morbid glial neoplasms of the thalamus or brainstem that typically arise in young children and are not surgically resectable. These tumors are characterized by a high rate of histone H3 mutation, resulting in repla...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tina Y., Piunti, Andrea, Lulla, Rishi R., Qi, Jin, Horbinski, Craig M., Tomita, Tadanori, James, C. David, Shilatifard, Ali, Saratsis, Amanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392913/
https://www.ncbi.nlm.nih.gov/pubmed/28416018
http://dx.doi.org/10.1186/s40478-017-0436-6
_version_ 1783229488692199424
author Huang, Tina Y.
Piunti, Andrea
Lulla, Rishi R.
Qi, Jin
Horbinski, Craig M.
Tomita, Tadanori
James, C. David
Shilatifard, Ali
Saratsis, Amanda M.
author_facet Huang, Tina Y.
Piunti, Andrea
Lulla, Rishi R.
Qi, Jin
Horbinski, Craig M.
Tomita, Tadanori
James, C. David
Shilatifard, Ali
Saratsis, Amanda M.
author_sort Huang, Tina Y.
collection PubMed
description Diffuse midline gliomas (including diffuse intrinsic pontine glioma, DIPG) are highly morbid glial neoplasms of the thalamus or brainstem that typically arise in young children and are not surgically resectable. These tumors are characterized by a high rate of histone H3 mutation, resulting in replacement of lysine 27 with methionine (K27M) in genes encoding H3 variants H3.3 (H3F3A) and H3.1 (HIST1H3B). Detection of these gain-of-function mutations has clinical utility, as they are associated with distinct tumor biology and clinical outcomes. Given the paucity of tumor tissue available for molecular analysis and relative morbidity of midline tumor biopsy, CSF-derived tumor DNA from patients with diffuse midline glioma may serve as a viable alternative for clinical detection of histone H3 mutation. We demonstrate the feasibility of two strategies to detect H3 mutations in CSF-derived tumor DNA from children with brain tumors (n = 11) via either targeted Sanger sequencing of H3F3A and HIST1H3B, or H3F3A c.83 A > T detection via nested PCR with mutation-specific primers. Of the six CSF specimens from children with diffuse midline glioma in our cohort, tumor DNA sufficient in quantity and quality for analysis was isolated from five (83%), with H3.3K27M detected in four (66.7%). In addition, H3.3G34V was identified in tumor DNA from a patient with supratentorial glioblastoma. Test sensitivity (87.5%) and specificity (100%) was validated via immunohistochemical staining and Sanger sequencing in available matched tumor tissue specimens (n = 8). Our results indicate that histone H3 gene mutation is detectable in CSF-derived tumor DNA from children with brain tumors, including diffuse midline glioma, and suggest the feasibility of “liquid biopsy” in lieu of, or to complement, tissue diagnosis, which may prove valuable for stratification to targeted therapies and monitoring treatment response. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0436-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5392913
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53929132017-04-17 Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma Huang, Tina Y. Piunti, Andrea Lulla, Rishi R. Qi, Jin Horbinski, Craig M. Tomita, Tadanori James, C. David Shilatifard, Ali Saratsis, Amanda M. Acta Neuropathol Commun Research Diffuse midline gliomas (including diffuse intrinsic pontine glioma, DIPG) are highly morbid glial neoplasms of the thalamus or brainstem that typically arise in young children and are not surgically resectable. These tumors are characterized by a high rate of histone H3 mutation, resulting in replacement of lysine 27 with methionine (K27M) in genes encoding H3 variants H3.3 (H3F3A) and H3.1 (HIST1H3B). Detection of these gain-of-function mutations has clinical utility, as they are associated with distinct tumor biology and clinical outcomes. Given the paucity of tumor tissue available for molecular analysis and relative morbidity of midline tumor biopsy, CSF-derived tumor DNA from patients with diffuse midline glioma may serve as a viable alternative for clinical detection of histone H3 mutation. We demonstrate the feasibility of two strategies to detect H3 mutations in CSF-derived tumor DNA from children with brain tumors (n = 11) via either targeted Sanger sequencing of H3F3A and HIST1H3B, or H3F3A c.83 A > T detection via nested PCR with mutation-specific primers. Of the six CSF specimens from children with diffuse midline glioma in our cohort, tumor DNA sufficient in quantity and quality for analysis was isolated from five (83%), with H3.3K27M detected in four (66.7%). In addition, H3.3G34V was identified in tumor DNA from a patient with supratentorial glioblastoma. Test sensitivity (87.5%) and specificity (100%) was validated via immunohistochemical staining and Sanger sequencing in available matched tumor tissue specimens (n = 8). Our results indicate that histone H3 gene mutation is detectable in CSF-derived tumor DNA from children with brain tumors, including diffuse midline glioma, and suggest the feasibility of “liquid biopsy” in lieu of, or to complement, tissue diagnosis, which may prove valuable for stratification to targeted therapies and monitoring treatment response. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0436-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-17 /pmc/articles/PMC5392913/ /pubmed/28416018 http://dx.doi.org/10.1186/s40478-017-0436-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Huang, Tina Y.
Piunti, Andrea
Lulla, Rishi R.
Qi, Jin
Horbinski, Craig M.
Tomita, Tadanori
James, C. David
Shilatifard, Ali
Saratsis, Amanda M.
Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
title Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
title_full Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
title_fullStr Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
title_full_unstemmed Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
title_short Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
title_sort detection of histone h3 mutations in cerebrospinal fluid-derived tumor dna from children with diffuse midline glioma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392913/
https://www.ncbi.nlm.nih.gov/pubmed/28416018
http://dx.doi.org/10.1186/s40478-017-0436-6
work_keys_str_mv AT huangtinay detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma
AT piuntiandrea detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma
AT lullarishir detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma
AT qijin detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma
AT horbinskicraigm detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma
AT tomitatadanori detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma
AT jamescdavid detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma
AT shilatifardali detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma
AT saratsisamandam detectionofhistoneh3mutationsincerebrospinalfluidderivedtumordnafromchildrenwithdiffusemidlineglioma